MRK Jun 2025 75.000 put
- Business Wire
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
RAHWAY, N.J., June 25, 2024--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza. The product is expected to be available at veterinary clinics and hospitals nationwide late this summer.
- Zacks
Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know
Merck (MRK) closed the most recent trading day at $132.96, moving +1.71% from the previous trading session.
- Insider Monkey
Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other healthcare stocks. You can also check out the 20 Most Valuable Healthcare Companies in the World here. Healthcare […]
